The results suggest that Fucoxanthin inhibits the expression of STAT3 in TCC cell lines, thereby downregulating Bcl-xL expression and increasing the sensitivity of TCC cell lines to cisplatin. Here, BCL2L1 is linked to tarsal-carpal coalition syndrome.